Patent · US Active

Compounds active towards nuclear receptors

US11447479B2 · kind B2 · utility

0Cited by
7References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 18, 2020
Grant dateSep 20, 2022
Priority date
Expiry dateMar 2, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D401/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed are compounds active towards nuclear receptors, pharmaceutical compositions containing the compounds and use of the compounds in therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.